Galenica Sante (Switzerland) Insiders
| GALE Stock | CHF 76.50 0.35 0.46% |
Galenica Sante employs about 5.5 K people. The company is managed by 10 executives with a total tenure of roughly 12873 years, averaging almost 1287.0 years of service per executive, having 551.7 employees per reported executive. Recap of Galenica Sante's management performance can provide insight into the venture performance.
| Jrg Kneubhler Insider Advisor |
| Marianne Ellenberger Insider Head HR |
Galenica |
Galenica Sante Management Team Effectiveness
The company has return on total asset (ROA) of 0.0492 % which means that it generated a profit of $0.0492 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1509 %, meaning that it generated $0.1509 on every $100 dollars invested by stockholders. Galenica Sante's management efficiency ratios could be used to measure how well Galenica Sante manages its routine affairs as well as how well it operates its assets and liabilities.Galenica Sante Workforce Comparison
Galenica Sante AG is one of the top stocks in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 32,358. Galenica Sante retains roughly 5,517 in number of employees claiming about 17% of stocks in Biotechnology industry.
The company has Profit Margin (PM) of 0.04 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.05 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.05. Galenica Sante AG Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Galenica Sante AG Price Series Summation is a cross summation of Galenica Sante price series and its benchmark/peer.
Galenica Sante Notable Stakeholders
A Galenica Sante stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Galenica Sante often face trade-offs trying to please all of them. Galenica Sante's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Galenica Sante's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Jrg Kneubhler | Advisor | Profile | |
| Marianne Ellenberger | Head HR | Profile | |
| Virginie Jeschka | Chief Officer | Profile | |
| Thomas Szuran | Chief Officer | Profile | |
| Daniele Madonna | Chief Officer | Profile | |
| Barbara Walchli | Gen Sec | Profile | |
| Christina Hertig | Head Communications | Profile | |
| Andreas Koch | Head Logistics | Profile | |
| Marc Werner | Chief Officer | Profile | |
| Felix Burkhard | CFO Relations | Profile |
About Galenica Sante Management Performance
The success or failure of an entity such as Galenica Sante AG often depends on how effective the management is. Galenica Sante management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Galenica management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Galenica management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Galenica AG operates as a healthcare provider in Switzerland and internationally. The company was incorporated in 2017 and is headquartered in Bern, Switzerland. Galenica Sant operates under Biotechnology classification in Switzerland and is traded on Switzerland Exchange. It employs 77 people.
Please note, the imprecision that can be found in Galenica Sante's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Galenica Sante AG. Check Galenica Sante's Beneish M Score to see the likelihood of Galenica Sante's management manipulating its earnings.
Galenica Sante Workforce Analysis
Traditionally, organizations such as Galenica Sante use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Galenica Sante within its industry.Galenica Sante Manpower Efficiency
Return on Galenica Sante Manpower
| Revenue Per Employee | 695.1K | |
| Revenue Per Executive | 383.5M | |
| Net Income Per Employee | 30.4K | |
| Net Income Per Executive | 16.8M |
Additional Tools for Galenica Stock Analysis
When running Galenica Sante's price analysis, check to measure Galenica Sante's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galenica Sante is operating at the current time. Most of Galenica Sante's value examination focuses on studying past and present price action to predict the probability of Galenica Sante's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galenica Sante's price. Additionally, you may evaluate how the addition of Galenica Sante to your portfolios can decrease your overall portfolio volatility.